S A Everett - JoVE Visualize

Showing results (41-50 of 48) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 48 results.

Family Planning Perspectives|August 26, 1998

Sexual behavior among U.S. high school students, 1990-1995C W Warren, J S Santelli, S A Everett, et al.

Anti-Cancer Drug Design|April 3, 1998

5-substituted analogues of 3-hydroxymethyl-5-aziridinyl-1-methyl-2-[1H-indole-4,7-dione]prop-2-en- 1-ol (EO9, NSC 382459) and their regioisomers as hypoxia-selective agents: structure-cytotoxicity in vitroM Jaffar, M A Naylor, N Robertson, et al.

Acta Crystallographica. Section C, Crystal Structure Communications|February 15, 2001

1-Methylindole-3-carboxaldehyde oxime derivativesR W Janes, B S Potter, M A Naylor, et al.

Journal of Medicinal Chemistry|October 9, 1999

Bioreductive activation of a series of indolequinones by human DT-diaphorase: structure-activity relationshipsR M Phillips, M A Naylor, M Jaffar, et al.

Journal of Medicinal Chemistry|July 18, 1997

2-Cyclopropylindoloquinones and their analogues as bioreductively activated antitumor agents: structure-activity in vitro and efficacy in vivoM A Naylor, M Jaffar, J Nolan, et al.

The British Journal of Cancer. Supplement|July 1, 1996

Chemical properties which control selectivity and efficacy of aromatic N-oxide bioreductive drugsP Wardman, K I Priyadarsini, M F Dennis, et al.

Bioorganic & Medicinal Chemistry Letters|February 17, 1999

Prodrugs for targeting hypoxic tissues: regiospecific elimination of aspirin from reduced indolequinonesM Jaffar, S A Everett, M A Naylor, et al.

Journal of Medicinal Chemistry|July 21, 1998

Indolequinone antitumor agents: reductive activation and elimination from (5-methoxy-1-methyl-4,7-dioxoindol-3-yl)methyl derivatives and hypoxia-selective cytotoxicity in vitroM A Naylor, E Swann, S A Everett, et al.

Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 48 results.

Family Planning Perspectives|August 26, 1998

Sexual behavior among U.S. high school students, 1990-1995C W Warren, J S Santelli, S A Everett, et al.

Anti-Cancer Drug Design|April 3, 1998

5-substituted analogues of 3-hydroxymethyl-5-aziridinyl-1-methyl-2-[1H-indole-4,7-dione]prop-2-en- 1-ol (EO9, NSC 382459) and their regioisomers as hypoxia-selective agents: structure-cytotoxicity in vitroM Jaffar, M A Naylor, N Robertson, et al.

Acta Crystallographica. Section C, Crystal Structure Communications|February 15, 2001

1-Methylindole-3-carboxaldehyde oxime derivativesR W Janes, B S Potter, M A Naylor, et al.

Journal of Medicinal Chemistry|October 9, 1999

Bioreductive activation of a series of indolequinones by human DT-diaphorase: structure-activity relationshipsR M Phillips, M A Naylor, M Jaffar, et al.

Journal of Medicinal Chemistry|July 18, 1997

2-Cyclopropylindoloquinones and their analogues as bioreductively activated antitumor agents: structure-activity in vitro and efficacy in vivoM A Naylor, M Jaffar, J Nolan, et al.

The British Journal of Cancer. Supplement|July 1, 1996

Chemical properties which control selectivity and efficacy of aromatic N-oxide bioreductive drugsP Wardman, K I Priyadarsini, M F Dennis, et al.

Bioorganic & Medicinal Chemistry Letters|February 17, 1999

Prodrugs for targeting hypoxic tissues: regiospecific elimination of aspirin from reduced indolequinonesM Jaffar, S A Everett, M A Naylor, et al.

Journal of Medicinal Chemistry|July 21, 1998

Indolequinone antitumor agents: reductive activation and elimination from (5-methoxy-1-methyl-4,7-dioxoindol-3-yl)methyl derivatives and hypoxia-selective cytotoxicity in vitroM A Naylor, E Swann, S A Everett, et al.

Pageof 5